These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 9046061
1. The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen. Hanisch FG, Baldus SE. Histol Histopathol; 1997 Jan; 12(1):263-81. PubMed ID: 9046061 [Abstract] [Full Text] [Related]
2. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. Campbell BJ, Finnie IA, Hounsell EF, Rhodes JM. J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740 [Abstract] [Full Text] [Related]
3. Expression of the pantumour Thomsen-Friedenreich antigen in the human placenta with the diagnosis of hydatidiform mole. Richter DU, Jeschke U, Makovitzky J, Gerber B, Briese V. Anticancer Res; 2007 Feb; 27(4A):2001-3. PubMed ID: 17649812 [Abstract] [Full Text] [Related]
4. Expression of the Thomsen-Friedenreich (TF) antigen in the human placenta. Richter DU, Jeschke U, Makovitzky J, Goletz S, Karsten U, Briese V, Friese K. Anticancer Res; 2000 Feb; 20(6D):5129-33. PubMed ID: 11326683 [Abstract] [Full Text] [Related]
5. Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry. Yuan M, Itzkowitz SH, Boland CR, Kim YD, Tomita JT, Palekar A, Bennington JL, Trump BF, Kim YS. Cancer Res; 1986 Sep; 46(9):4841-7. PubMed ID: 3731131 [Abstract] [Full Text] [Related]
6. Expression of the carbohydrate tumour marker SLeX, SLeA (CA19-9), LeY and Thomsen-Friedenreich (TF) antigen on normal squamous epithelial tissue of the penis and vagina. Wiest I, Schulze S, Kuhn C, Seliger C, Hausmann R, Betz P, Mayr D, Friese K, Jeschke U. Anticancer Res; 2007 Sep; 27(4A):1981-8. PubMed ID: 17649809 [Abstract] [Full Text] [Related]
7. Expression of the Thomsen-Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in vitro. Jeschke U, Richter DU, Hammer A, Briese V, Friese K, Karsten U. Histochem Cell Biol; 2002 Mar; 117(3):219-26. PubMed ID: 11914919 [Abstract] [Full Text] [Related]
8. Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries. Peletskaya EN, Glinsky VV, Glinsky GV, Deutscher SL, Quinn TP. J Mol Biol; 1997 Jul 18; 270(3):374-84. PubMed ID: 9237904 [Abstract] [Full Text] [Related]
9. Mucin 1, Thomsen-Friedenreich expression and galectin-1 binding in endometrioid adenocarcinoma: an immunohistochemical analysis. Mylonas I, Mayr D, Walzel H, Shabani N, Dian D, Kuhn C, Kunze S, Jeschke U, Friese K. Anticancer Res; 2007 Jul 18; 27(4A):1975-80. PubMed ID: 17649808 [Abstract] [Full Text] [Related]
10. Expression of the Thomsen-Friedenreich (TF) tumor antigen in human abort placentas. Richter DU, Jeschke U, Bergemann C, Makovitzky J, Lüthen F, Karsten U, Briese V. Anticancer Res; 2005 Jul 18; 25(3A):1675-8. PubMed ID: 16033081 [Abstract] [Full Text] [Related]
11. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. Glinsky VV, Huflejt ME, Glinsky GV, Deutscher SL, Quinn TP. Cancer Res; 2000 May 15; 60(10):2584-8. PubMed ID: 10825125 [Abstract] [Full Text] [Related]
12. Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection. Kumar SR, Sauter ER, Quinn TP, Deutscher SL. Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6868-71. PubMed ID: 16203776 [Abstract] [Full Text] [Related]
13. Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: A clinicopathologic study of 264 patients. Baldus SE, Zirbes TK, Hanisch FG, Kunze D, Shafizadeh ST, Nolden S, Mönig SP, Schneider PM, Karsten U, Thiele J, Hölscher AH, Dienes HP. Cancer; 2000 Apr 01; 88(7):1536-43. PubMed ID: 10738210 [Abstract] [Full Text] [Related]
14. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients. Schindlbeck C, Jeschke U, Schulze S, Karsten U, Janni W, Rack B, Krajewski S, Sommer H, Friese K. Breast Cancer Res Treat; 2007 Jan 01; 101(1):17-25. PubMed ID: 16807671 [Abstract] [Full Text] [Related]
15. A new monoclonal antibody (A78-G/A7) to the Thomsen-Friedenreich pan-tumor antigen. Karsten U, Butschak G, Cao Y, Goletz S, Hanisch FG. Hybridoma; 1995 Feb 01; 14(1):37-44. PubMed ID: 7539400 [Abstract] [Full Text] [Related]
16. The Thomsen-Friedenreich antigen on human urothelial cell lines detectable by peanut lectin and monoclonal antibody raised against human glycophorin A. Radzikowski CZ, Steuden I, Wiedlocha A, Kieler J, Tromholt V. Anticancer Res; 1989 Feb 01; 9(1):103-7. PubMed ID: 2650614 [Abstract] [Full Text] [Related]
18. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas. Jeschke U, Mayr D, Schiessl B, Mylonas I, Schulze S, Kuhn C, Friese K, Walzel H. Placenta; 2007 Feb 01; 28(11-12):1165-73. PubMed ID: 17664004 [Abstract] [Full Text] [Related]
19. Immunodiagnostic potential of mucin (MUC2) and Thomsen-Friedenreich (TF) antigens in Egyptian patients with colorectal cancer. El-Sayed IH, Lotfy M, Moawad M. Eur Rev Med Pharmacol Sci; 2011 Jan 01; 15(1):91-7. PubMed ID: 21381504 [Abstract] [Full Text] [Related]
20. Multivalent scFv display of phagemid repertoires for the selection of carbohydrate-specific antibodies and its application to the Thomsen-Friedenreich antigen. Ravn P, Danielczyk A, Jensen KB, Kristensen P, Christensen PA, Larsen M, Karsten U, Goletz S. J Mol Biol; 2004 Oct 29; 343(4):985-96. PubMed ID: 15476815 [Abstract] [Full Text] [Related] Page: [Next] [New Search]